Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 6, 2014, Pages 519-535

  Tarabal, Olga ^a   Caraballo Miralles, Víctor ^b   Cardona Rossinyol, Andrea ^b   Correa, Francisco J ^a   Olmos, Gabriel ^b   Lladó, Jerònia ^b   Esquerda, Josep E ^a   Calderó, Jordi ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Glia; Motoneuron; Nitric oxide; RhoA ROCK pathway; SMN 7 mouse; Spinal muscular atrophy; Synaptic afferents

Indexed keywords

CD68 ANTIGEN; MYOSIN LIGHT CHAIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN; PROTEIN IBA 1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; NERVE PROTEIN; SMN2 PROTEIN, HUMAN; SURVIVAL MOTOR NEURON PROTEIN 2; VESICULAR INHIBITORY AMINO ACID TRANSPORTER; VIAAT PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DEAFFERENTATION; DEGENERATION; DENDRITE; EXCITABILITY; GLIOSIS; IMMUNOREACTIVITY; LUMBAR SPINAL CORD; MICROGLIA; MOTONEURON; MOUSE; NEUROFILAMENT; NONHUMAN; PHAGOCYTOSIS; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPINAL CORD DISEASE; SPINAL CORD VENTRAL HORN; SPINAL MUSCULAR ATROPHY; SYNAPSE; SYNAPTOSOME; UPREGULATION; ANIMAL; C57BL MOUSE; CELL COUNT; COMPLICATION; DISEASE MODEL; ECHOGRAPHY; EXON; GENE DELETION; GENETICS; METABOLISM; NERVE DEGENERATION; NEWBORN; PATHOLOGY; SPINAL CORD; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; ANIMALS, NEWBORN; CALCIUM-BINDING PROTEINS; CELL COUNT; DISEASE MODELS, ANIMAL; EXONS; GENE DELETION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; NERVE DEGENERATION; NERVE TISSUE PROTEINS; SPINAL CORD; SURVIVAL OF MOTOR NEURON 2 PROTEIN; SYNAPSES; UP-REGULATION; VESICULAR INHIBITORY AMINO ACID TRANSPORT PROTEINS;

EID: 84901344068     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000074     Document Type: Article

References (98)

1. Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 1996;3:97-110
2. Emery AE. Population frequencies of inherited neuromuscular diseases Va world survey. Neuromuscul Disord 1991;1:19-29
3. Lefebvre S, Bürglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophyYdetermining gene. Cell 1995;80: 155-65
4. Pellizzoni L, Kataoka N, Charroux B, et al. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 1998;95:615-24
5. Gennarelli M, Lucarelli M, Capon F, et al. Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 1995;213:342-48
6. Le TT, Pham LT, Butchbach MER, et al. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 2005;14:845-57
7. Schrank B, Gotz R, Gunnersen JM, et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci USA 1997;94:9920-25
8. Avila AM, Burnett BG, Taye AA, et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest 2007;117:659-71
9. Murray LM, Comley LH, Thomson D, et al. Selective vulnerability of motor neurons and dissociation of pre-and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet 2008;17:949-62
10. Lotti F, Imlach WL, Saieva L, et al. An SMN-dependent U12 splicing event essential for motor circuit function. Cell 2012;151:440-54
11. Byers RK, Banker BQ. Infantile muscular atrophy. Arch Neurol 1961;5: 140-64
12. Dachs E, Hereu M, Piedrafita L, et al. Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy. J Neuropathol Exp Neurol 2011;70:444-61
13. Dachs E, Piedrafita L, Hereu M, et al. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy. Neuroscience 2013;250:417-33
14. Ito Y, Shibata N, Saito K, et al. New insights into the pathogenesis of spinal muscular atrophy. Brain Dev 2011;33:321-31
15. Kariya S, Park G-H, Maeno-Hikichi Y, et al. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet 2008;17:2552-69
16. Monani UR, Sendtner M, Coovert DD, et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(j/j) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 2000;9:333-39
17. Kong L, Wang X, Choe DW, et al. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci 2009;29:842-51
18. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005;50:427-34
19. Eikelenboom P, Bate C, Van Gool WA, et al. Neuroinflammation in Alzheimer?s disease and prion disease. Glia 2002;40:232-39
20. Evans MC, Couch Y, Sibson N, et al. Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol Cell Neurosci 2013;53: 34-41
21. Frank-Cannon TC, Alto LT, McAlpine FE, et al. Does neuroinflammation fan the flame in neurodegenerative diseases Mol Neurodegener 2009;4:47
22. McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 2002;26:459-70
23. Moisse K, Strong MJ. Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 2006;1762:1083-93
24. Sargsyan SA, Monk PN, Shaw PJ. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 2005;51: 241-53
25. Ling KKY, Lin M-Y, Zingg B, et al. Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy. PLoS One 2010;5:e15457
26. McGivern JV, Patitucci TN, Nord JA, et al. Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production. Glia 2013;61:1418-28
27. Papadimitriou D, Le Verche V, Jacquier A, et al. Inflammation in ALS and SMA: Sorting out the good from the evil. Neurobiol Dis 2010;37: 493-502
28. Eroglu C, Barres BA. Regulation of synaptic connectivity by glia. Nature 2010;468:223-31
29. Cifuentes-Diaz C, Nicole S, Velasco ME, et al. Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum Mol Genet 2002;11:1439-47
30. Ling KK, Gibbs RM, Feng Z, et al. Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. Hum Mol Genet 2012;21:185-95
31. Murray LM, Talbot K, Gillingwater TH. Review: Neuromuscular synaptic vulnerability in motor neurone disease: Amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol Appl Neurobiol 2010;36: 133-56
32. Torres-Benito L, Neher MF, Cano R, et al. SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals. PLoS One 2011;6:e26164
33. Mentis GZ, Blivis D, Liu W, et al. Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron 2011;69:453-67
34. Park G-H, Maeno-Hikichi Y, Awano T, et al. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J Neurosci 2010;30:12005-19
35. Sunico CR, Portillo F, Gonzalez-Forero D, et al. Nitric-oxideYdirected synaptic remodeling in the adult mammal CNS. J Neurosci 2005;25:1448-58
36. Sunico CR, Gonzalez-Forero D, Dominguez G, et al. Nitric oxide induces pathological synapse loss by a protein kinase GY, Rho kinaseYdependent mechanism preceded by myosin light chain phosphorylation. J Neurosci 2010;30:973-84
37. Calderó J, Ciutat D, Lladó J, et al. Effects of excitatory amino acids on neuromuscular development in the chick embryo. J Comp Neurol 1997; 387:73-95
38. Clarke PG, Oppenheim RW. Neuron death in vertebrate development: In vitro methods. Methods Cell Biol 1995;46:277-321
39. Conradi S, Kellerth JO, Berthold CH. Electron microscopic studies of serially sectioned cat spinal alpha-motoneurons. II. A method for the description of architecture and synaptology of the cell body and proximal dendritic segments. J Comp Neurol 1979;184:741-54
40. Ackerley S, Grierson AJ, Banner S, et al. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol Cell Neurosci 2004;26:354-64
41. Olney JW, Ishimaru MJ. Excitotoxic cell death. In: Koliatsos VE, Ratan RR, eds. Cell Death and Diseases of the Nervous System. Totowa, NJ: Humana Press Inc, 1999:197-219
42. Fidzianska A, Rafalowska J. Motoneuron death in normal and spinal muscular atrophyYaffected human fetuses. Acta Neuropathol 2002;104: 363-68
43. Brunet N, Tarabal O, Portero-Otin M, et al. Survival and death of mature avian motoneurons in organotypic slice culture: Trophic requirements for survival and different types of degeneration. J Comp Neurol 2007;501: 669-90
44. Chiu IM, Phatnani H, Kuligowski M, et al. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci USA 2009;106:20960-65
45. Oliveira AL, Hydling F, Olsson E, et al. Cellular localization of three vesicular glutamate transporter mRNAs and proteins in rat spinal cord and dorsal root ganglia. Synapse 2003;50:117-29
46. Lawson SJ, Davies HJ, Bennett JP, et al. Evidence that spinal interneurons undergo programmed cell death postnatally in the rat. Eur J Neurosci 1997;9:794-99
47. Peviani M, Salvaneschi E, Bontempi L, et al. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Neurobiol Dis 2014;62C: 218-32
48. Bodian D. Electron microscopy: Two major synaptic types on spinal motoneurons. Science 1966;151:1093-94
49. Zagoraiou L, Akay T, Martin JF, et al. A cluster of cholinergic premotor interneurons modulates mouse locomotor activity. Neuron 2009;64: 645-62
50. Pullen AH, Athanasiou D. Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. Eur J Neurosci 2009;29:551-61
51. Saxena S, Roselli F, Singh K, et al. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 2013;80:80-96
52. Vinsant S, Mansfield C, Jimenez-Moreno R, et al. Characterization of early pathogenesis in the SOD1 G93A mouse model of ALS. Part I. Background and methods. Brain Behav 2013;3:335-50
53. Vinsant S, Mansfield C, Jimenez-Moreno R, et al. Characterization of early pathogenesis in the SOD1 G93A mouse model of ALS. Part II. Results and discussion. Brain Behav 2013;3:431-57
54. Moreno-Lopez B, Sunico CR, Gonzalez-Forero D. NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: Modeling a molecular mechanism. Mol Neurobiol 2011;43:41-66
55. Luo L. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 2000;1:173-80
56. Luo L. Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity. Annu Rev Cell Dev Biol 2002;18:601-35
57. Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996;271: 20246-49
58. Imlach WL, Beck ES, Choi BJ, et al. SMN is required for sensory-motor circuit function in Drosophila. Cell 2012;151:427-39
59. Bowerman M, Anderson CL, Beauvais A, et al. SMN, profilin IIa and plastin 3: A link between the deregulation of actin dynamics and SMA pathogenesis. Mol Cell Neurosci 2009;42:66-74
60. Grondard C, Biondi O, Armand AS, et al. Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 2005;25:7615-22
61. Jablonka S, Schrank B, Kralewski M, et al. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: An animal model for spinal muscular atrophy type III. Hum Mol Genet 2000; 9:341-46
62. Hirano A, Nakano I, Kurland LT, et al. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1984;43:471-80
63. Frugier T, Tiziano FD, Cifuentes-Diaz C, et al. Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Hum Mol Genet 2000;9:849-58
64. Gould TW, Buss RR, Vinsant S, et al. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci 2006;26:8774-86
65. Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease. Lancet Neurol 2011;10:253-63
66. Chou SM. Glial bundles of nerve roots in Werdnig-Hoffmann disease. Ann Neurol 1980;8:79-82
67. Ghatak NR. Glial bundles in spinal nerve roots: A form of isomorphic gliosis at the junction of the central and peripheral nervous system. Neuropathol Appl Neurobiol 1983;9:391-401
68. Kumagai T, Hashizume Y. Morphological and morphometric studies on the spinal cord lesion in Werdnig-Hoffmann disease. Brain Dev 1982; 4:87-96
69. Kuru S, Sakai M, Konagaya M, et al. An autopsy case of spinal muscular atrophy type III (Kugelberg-Welander disease). Neuropathology 2009; 29:63-67
70. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-18
71. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol 1999;57:563-81
72. Streit WJ, Graeber MB, Kreutzberg GW. Functional plasticity of microglia: A review. Glia 1988;1:301-7
73. Calderó J, Brunet N, Ciutat D, et al. Development of microglia in the chick embryo spinal cord: Implications in the regulation of motoneuronal survival and death. J Neurosci Res 2009;87:2447-66
74. Caraballo-Miralles V, Cardona-Rossinyol A, Garcera A, et al. Notch signaling pathway is activated in motoneurons of spinal muscular atrophy. Int J Mol Sci 2013;14:11424-37
75. Morga E, Mouad-Amazzal L, Felten P, et al. Jagged1 regulates the activation of astrocytes via modulation of NFkappaB and JAK/STAT/SOCS pathways. Glia 2009;57:1741-53
76. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16:675-86
77. Di Giorgio FP, Carrasco MA, Siao MC, et al. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cellYbased ALS model. Nat Neurosci 2007;10:608-14
78. Haidet-Phillips AM, Hester ME, Miranda CJ, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 2011;29:824-28
79. Nagai M, Re DB, Nagata T, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007;10:615-22
80. Panatier A, Vallee J, Haber M, et al. Astrocytes are endogenous regulators of basal transmission at central synapses. Cell 2011;146:785-98
81. Emirandetti A, Graciele Zanon R, Sabha M Jr, et al. Astrocyte reactivity influences the number of presynaptic terminals apposed to spinal motoneurons after axotomy. Brain Res 2006;1095:35-42
82. Ullian EM, Sapperstein SK, Christopherson KS, et al. Control of synapse number by glia. Science 2001;291:657-61
83. Purves D, Lichtman JW. Elimination of synapses in the developing nervous system. Science 1980;210:153-57
84. Bowerman M, Shafey D, Kothary R. Smn depletion alters profilin II expression and leads to upregulation of the RhoA/ROCK pathway and defects in neuronal integrity. J Mol Neurosci 2007;32:120-31
85. Selkoe DJ. Alzheimer?s disease is a synaptic failure. Science 2002;298: 789-91
86. Ince PG, Slade J, Chinnery RM, et al. Quantitative study of synaptophysin immunoreactivity of cerebral cortex and spinal cord in motor neuron disease. J Neuropathol Exp Neurol 1995;54:673-79
87. Sasaki S, Maruyama S. Synapse loss in anterior horn neurons in amyotrophic lateral sclerosis. Acta Neuropathol 1994;88:222-27
88. Wishart TM, Parson SH, Gillingwater TH. Synaptic vulnerability in neurodegenerative disease. J Neuropathol Exp Neurol 2006;65:733-39
89. Ikemoto A, Hirano A, Matsumoto S, et al. Synaptophysin expression in the anterior horn of Werdnig-Hoffmann disease. J Neurol Sci 1996; 136:94-100
90. Yamanouchi Y, Yamanouchi H, Becker LE. Synaptic alterations of anterior horn cells in Werdnig-Hoffmann disease. Pediatr Neurol 1996;15:32-35
91. Jablonka S, Karle K, Sandner B, et al. Distinct and overlapping alterations in motor and sensory neurons in a mouse model of spinal muscular atrophy. Hum Mol Genet 2006;15:511-18
92. Gogliotti RG, Quinlan KA, Barlow CB, et al. Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction. J Neurosci 2012;32:3818-29
93. Martinez TL, Kong L, Wang X, et al. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. J Neurosci 2012;32:8703-15
94. Thirumalai V, Behrend RM, Birineni S, et al. Preservation of VGLUT1 synapses on ventral calbindin-immunoreactive interneurons and normal locomotor function in a mouse model of spinal muscular atrophy. J Neurophysiol 2013;109:702-10
95. Ruan YW, Han XJ, Shi ZS, et al. Remodeling of synapses in the CA1 area of the hippocampus after transient global ischemia. Neuroscience 2012;218:268-77
96. Bowen S, Ateh DD, Deinhardt K, et al. The phagocytic capacity of neurones. Eur J Neurosci 2007;25:2947-55
97. Sumner BE. A quantitative analysis of boutons with different types of synapse in normal and injured hypoglossal nuclei. Exp Neurol 1975;49: 406-17
98. Bowerman M, Beauvais A, Anderson CL, et al. Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Hum Mol Genet 2010;19:1468-78